Further studies are required to elucidate the relationship between the neutralizing ability of antibodies formed following COVID-19 vaccination and their ability to bind C1q and activate complement and whether the observed binding of MBL in this study has a role in neutralization in ways other than complement activation. This evidence concerns the gene MBL2 and COVID-19.